Mark A. Murakami

2.7k citations

30 papers · 909 indexed · 1 hit paper · h-index 9

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
Genetics top 10%
- Blood disorders and treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Genetics 10
- Chronic Lymphocytic Leukemia Research 8
Hematology 10
- Chronic Myeloid Leukemia Treatments 5
- Acute Myeloid Leukemia Research 4

Co-authors: David M. Weinstock Daniel C. Link Scott R. Manalis Jun Xia Marlise R. Luskin David S. Grenda Mary C. Dinauer Laurence A. Boxer
Journals: Blood (14 papers)Journal of Clinical Oncology (2 papers)Nature Biotechnology (2 papers)Nature Biomedical Engineering (1 paper)HemaSphere (1 paper)
Partner nations: United States South Africa Japan

In The Last Decade

Mark A. Murakami

28 papers receiving 903 citations

Hit Papers

align trajectories log scale

Distinction of lymphoid and myeloid clonal hematopoiesis 2021 · 161 citations

Peers

Countries citing papers authored by Mark A. Murakami

Since Specialization

Citations

This map shows the geographic impact of Mark A. Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Murakami more than expected).

Fields of papers citing papers by Mark A. Murakami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Murakami. The network helps show where Mark A. Murakami may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark A. Murakami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Murakami Line = papers co-authored together Mark A. Murakami links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	High-throughput single-cell density measurements enable dynamic profiling of immune cell and drug response from patient samples Nature Biomedical Engineering ·عبدالرحمن أحمد صلاح قراعة, 川添浩太朗, R.M. Plowes, Smitha Yerrum, Ye Zhang, 黄代洪, GABRIELLE CIVIL, Shobha De, Mark A. Murakami, Morvarid Mohseni, Kin-Hoe Chow, Teemu P. Miettinen, Keith L. Ligon, Scott R. Manalis	2025	1
2	Abstract 5145: E-selectin binding is enriched within B-cell acute lymphoblastic leukemia compared to healthy lymphoid precursors Cancer Research ·黃柏凱, M. Antonia Bolívar-Raya, D. Salon, 偉三雄山崎, Aléssio Martins Gonçalves, Marlise R. Luskin, Robert Sackstein, Mark A. Murakami	2025	1
3	Mutational signature analysis of chronic lymphocytic leukemia uncovering genomic patterns and prognostic implications American Journal of Clinical Pathology ·주철홍, Lorilyn Jacobsen-Tews, D Bezos, Chelo Fernández, Elizabeth F. Cohen, David M. Meredith, Mark A. Murakami, Lynette M. Sholl, Michael Tolstorukov, Harrison Tsai, Jonathan M. Tsai, David Zemmour, Neal I. Lindeman, Elizabeth Garcia, Intan Seprina Anugrah, Annette S. Kim	2025	0
4	A phase I study of asciminib in combination with dasatinib, prednisone, and blinatumomab for Ph-positive acute leukemia in adults. Journal of Clinical Oncology ·Marlise R. Luskin, Mark A. Murakami, Aléssio Martins Gonçalves, Eunice S. Wang, Malgorzata McMasters, Yael Flamand, Eric S. Winer, Maximilian Stahl, Hunter Smith, 偉三雄山崎, 黃柏凱, Jason B. Fleming, Caner Saygin, Wendy Stock, Daniel J. DeAngelo	2025	0
5	Bone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow Alliance Transplantation and Cellular Therapy ·Mark A. Murakami, Laura Connelly‐Smith, Thomas R. Spitzer, Adetola A. Kassim, Sam Penza, Monzr M. Al Malki, James R. Mason, L Nolff, F. J. Bresnock, M. Luisa Asy Guerrero Muñoz, Priti Gangwar, Jamie Margolis, Steven M. Devine, E C Vigiliani, Heather E. Stefanski	2024	3
6	A pilot study of axicabtagene ciloleucel (axi-cel) for relapsed/refractory primary and secondary central nervous system lymphoma (PCNSL and SCNSL). Journal of Clinical Oncology ·Lakshmi Nayak, Ugonma Chukwueke, Christopher Meehan, Robert Redd, Sarah Hogan, Eudocia Q. Lee, Beatriz Clemencia, Isabel Arrillaga‐Romany, KroidlR, L. Nicolas Gonzalez Castro, Mark A. Murakami, Raymond Y. Huang, Ulrike Gerdemann, James J. Kaminski, Simone Filosto, Soumya Poddar, Mike Mattie, Philippe Armand, Leslie S. Kean, Caron A. Jacobson	2024	9
7	Comparison of whole‐genome and immunoglobulin‐based circulating tumor DNA assays in diffuse large B‐cell lymphoma HemaSphere ·Reid W. Merryman, Justin Rhoades, Kan Xiong, Robert Redd, D Bezos, 髙橋利之, Bruno César Ribas, Hanny J.D., Yao Yves AHOUMAN, Sainetra Sridhar, Timothy Blewett, Karla Ximena, Parastoo B. Dahi, Yago Nieto, Robin Joyce, Yi‐Bin Chen, Alex F. Herrera, Philippe Armand, Mark A. Murakami, Viktor A. Adalsteinsson	2024	1
8	Asciminib plus dasatinib and prednisone for Philadelphia chromosome–positive acute leukemia Blood ·Marlise R. Luskin, Mark A. Murakami, Aléssio Martins Gonçalves, Yael Flamand, Eric S. Winer, Jacqueline S. Garcia, Maximilian Stahl, Richard M. Stone, Martha Wadleigh, 偉三雄山崎, Kátia Teresinha Cabrini, David M. Weinstock, 文子若尾, Malgorzata McMasters, Eunice S. Wang, Wendy Stock, Daniel J. DeAngelo	2024	6
9	A Personalized Whole Genome-Informed Assay Targeting Single Mutant in Circulating Tumor DNA Can Identify MRD and Predict Relapse in DLBCL Blood ·Reid W. Merryman, Justin Rhoades, Kan Xiong, D Bezos, 髙橋利之, Robert Redd, Bruno César Ribas, Richard Truse, Jason P. Klein, Sainetra Sridhar, Timothy Blewett, 杜松楠, Parastoo B. Dahi, Yago Nieto, Yi‐Bin Chen, Alex F. Herrera, Robin Joyce, Philippe Armand, Mark A. Murakami, Viktor A. Adalsteinsson	2023	2
10	Protein re-surfacing of E. coli L-Asparaginase to evade pre-existing anti-drug antibodies and hypersensitivity responses Frontiers in Immunology ·Tadele Jabamo, 髙橋利之, Zuraidah Tharo, Ririn Agustin, Y. Zhao, Khaled El Aloul, Joseph D. Garlick, Aneja, Michael E. Hudson, Gevorg Grigoryan, Mark A. Murakami, Kristen Hopson, Daniel S. Leventhal	2022	6
11	Distinction of lymphoid and myeloid clonal hematopoiesis Nature Medicine ·Abhishek Niroula, Aswin Sekar, Mark A. Murakami, Mark Trinder, Mridul Agrawal, Waihay J. Wong, Alexander G. Bick, Md Mesbah Uddin, Christopher J. Gibson, Gabriel K. Griffin, Michael C. Honigberg, Seyedeh M. Zekavat, Kaavya Paruchuri, Pradeep Natarajan, Benjamin L. Ebert Hit paper breakdown →	2021	161
12	A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL in Adults Blood ·Marlise R. Luskin, Kristen E. Stevenson, Lourdes Mendez, Eunice S. Wang, Martha Wadleigh, Jacqueline S. Garcia, Richard M. Stone, 髙橋利之, Kátia Teresinha Cabrini, Ilene Galinsky, 良治桜田, Rebecca Leonard, Daniel J. DeAngelo, Mark A. Murakami	2021	8
13	Leveraging Pathway-Interference to Overcome Drug-Resistance in Acute Lymphoblastic Leukemia Blood ·Lai N. Chan, Mark A. Murakami, Christian Hurtz, Kohei Kume, Jae Woong Lee, Kadriye Nehir Cosgun, Huimin Geng, Shai Izraeli, David M. Weinstock, Markus Müschen	2021	1
14	Targeting minimal residual disease: a path to cure? Nature reviews. Cancer ·Marlise R. Luskin, Mark A. Murakami, Scott R. Manalis, David M. Weinstock	2018	97
15	An ED pilot intervention to facilitate outpatient acute care for cancer patients The American Journal of Emergency Medicine ·Gabriel A. Brooks, D. A. Zerkal, Mark A. Murakami, Marios Giannakis, Christopher W. Baugh, Deborah Schrag	2016	8
16	Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate Nature Biotechnology ·Mark M. Stevens, Cécile L. Maire, Nigel Chou, Mark A. Murakami, David Knoff, Yuki Kikuchi, Robert Kimmerling, Huiyun Liu, Samer Haidar, Nicholas L. Calistri, Nathan Cermak, Selim Olçum, Nicolas A. Cordero, Ahmed Idbaïh, Patrick Y. Wen, David M. Weinstock, Keith L. Ligon, Scott R. Manalis	2016	74
17	High-throughput measurement of single-cell growth rates using serial microfluidic mass sensor arrays Nature Biotechnology ·Nathan Cermak, Selim Olçum, Francisco Feijó Delgado, Steven C. Wasserman, Kristofor R. Payer, Mark A. Murakami, Scott M. Knudsen, Robert Kimmerling, Mark M. Stevens, Yuki Kikuchi, Arzu Sandikci, Masaaki Ogawa, Vincent Agache, F. Baleras, David M. Weinstock, Scott R. Manalis	2016	170
18	The MDM2 Inhibitor NVP-CGM097 Is Highly Active in a Randomized Preclinical Trial of B-Cell Acute Lymphoblastic Leukemia Patient Derived Xenografts Blood ·Elizabeth C. Townsend, Tiffany DeSouza, Mark A. Murakami, Joan Montero, Kristen E. Stevenson, Amanda L. Christie, M Okano, Shalini Chinna, Nadja Kopp, Patrizia Barzaghi-Rinaudo, Masato Murakami, Anthony Letai, Sébastien Jeay, Jens Wuerthner, Ensar Halilovic, David M. Weinstock	2015	8
19	High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples Journal of Clinical Investigation ·Jacqueline E. Payton, Nicole R. Grieselhuber, Li‐Wei Chang, Mark A. Murakami, Gary Geiss, Daniel C. Link, Rakesh Nagarajan, Mark A. Watson, Timothy J. Ley	2009	111
20	[A remission case of Ph1 positive acute myeloid leukemia]. PubMed ·Akio OHKUMA, Jun Takeuchi, Jodi Murakami, Mark A. Murakami, Yûji Hayakawa, Baba M, Deni Juričan, Umihiko Sawada, 朱文川, Takashi Ohshima, K. Kontani	1982	2

About Mark A. Murakami

Mark A. Murakami is a scholar working on Genetics, Hematology, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 30 papers that have together received 909 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), CAR-T cell therapy research (7 papers), Acute Lymphoblastic Leukemia research (7 papers), Chronic Myeloid Leukemia Treatments (5 papers), Cancer Genomics and Diagnostics (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (4 papers) and Erythrocyte Function and Pathophysiology (3 papers). The work is most often cited by research in Hematology (230 citations), Genetics (117 citations), Cancer Research (160 citations), Immunology (174 citations) and Genetics (221 citations). Mark A. Murakami has collaborated with scholars based in United States, South Africa and Japan. Frequent co-authors include David M. Weinstock, Daniel C. Link, Scott R. Manalis, Jun Xia, Marlise R. Luskin, David S. Grenda, Mary C. Dinauer, Laurence A. Boxer, David C. Dale and Yuki Kikuchi. Their work appears in journals such as Blood, Journal of Clinical Oncology, Nature Biotechnology, Nature Biomedical Engineering and HemaSphere.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact